Karen Prange
SVP&Pres, Uro & Women's Health, Boston Scientific.
Companies
- Outset Medical, Inc.Board member Jan 12, 2026 to now1
- Embecta Corp.Board member Apr 5, 2022 to now2
- AtriCure (United States)Board member Dec 4, 2019 to now3
- NEVRO CORPBoard member Dec 18, 2019 to Apr 3, 20254
- ViewRayBoard member Jun 15, 2021 to Jul 21, 20235
- Henry ScheinChief executive officer May 20, 2016 to Mar 6, 20186
- Boston ScientificSVP&Pres, Uro & Women's Health Jan 9, 2013 to Mar 8, 20167
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- AtriCure (United States) ATRC22,809 shares8$1.3M at $57.08Aug 5, 2026
- Embecta Corp. EMBC64,581 shares9$403.0K at $6.24Feb 11, 2026
- Outset Medical, Inc. OM29,334 shares10$119.4K at $4.07Jun 4, 2026
- NEVRO CORP0 shares11Apr 3, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 5, 2026Sold 3,564 shares at $38.80 of AtriCure (United States)8
- Jun 4, 2026Granted 10,667 shares of Outset Medical, Inc.10
- May 20, 2026Sold 3,000 shares at $28.65 of AtriCure (United States)12
- May 18, 2026Granted 6,144 shares of AtriCure (United States)13
- Feb 11, 2026Granted 22,841 shares of Embecta Corp.9
- Jan 9, 2026Granted 18,667 shares of Outset Medical, Inc.14
- May 19, 2025Granted 5,401 shares of AtriCure (United States)15
- Apr 3, 2025Returned to company 33,948 shares of NEVRO CORP11
- Mar 5, 2025Sold 6,100 shares at $38.12 of AtriCure (United States)16
- Feb 12, 2025Granted 13,839 shares of Embecta Corp.17
- May 23, 2024Granted 19,169 shares of NEVRO CORP18
- May 13, 2024Granted 7,788 shares of AtriCure (United States)19
- Feb 7, 2024Granted 11,455 shares of Embecta Corp.20
- Jul 21, 2023Sold 37,600 shares at $0.05 of CIK 159731321
- Jul 19, 2023Sold 91,866 shares at $0.08 of CIK 159731321
- Jun 8, 2023Sold 713 shares at $47.89 of AtriCure (United States)22
- May 25, 2023Granted 3,186 shares of AtriCure (United States)23
- May 25, 2023Granted 6,754 shares of NEVRO CORP24
- Feb 9, 2023Granted 6,979 shares of Embecta Corp.25
- Jun 13, 2022Granted 54,511 shares of CIK 159731326
- May 26, 2022Granted 4,155 shares of NEVRO CORP27
- May 25, 2022Granted 3,564 shares of AtriCure (United States)28
- May 10, 2022Bought 26,300 shares at $2.66 of CIK 159731329
- May 10, 2022Bought 10,000 shares at $2.66 of CIK 159731329
- May 10, 2022Bought 1,300 shares at $2.66 of CIK 159731329
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAROutset Medical, Inc., Board member
- 2SEC EDGAREmbecta Corp., Board member
- 3
- 4SEC EDGARNEVRO CORP, Board member
- 5SEC EDGARViewRay, Board member
- 6
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARForm 4 filed May 22, 2026
- 13SEC EDGARForm 4 filed May 20, 2026
- 14SEC EDGARForm 4 filed Jan 12, 2026
- 15SEC EDGARForm 4 filed May 21, 2025
- 16SEC EDGARForm 4 filed Mar 7, 2025
- 17SEC EDGARForm 4 filed Feb 14, 2025
- 18SEC EDGARForm 4 filed May 28, 2024
- 19SEC EDGARForm 4 filed May 14, 2024
- 20SEC EDGARForm 4 filed Feb 9, 2024
- 21SEC EDGARForm 4 filed Jul 21, 2023
- 22SEC EDGARForm 4 filed Jun 12, 2023
- 23SEC EDGARForm 4 filed May 26, 2023
- 24SEC EDGARForm 4 filed May 30, 2023
- 25SEC EDGARForm 4 filed Feb 10, 2023
- 26SEC EDGARForm 4 filed Jun 15, 2022
- 27SEC EDGARForm 4 filed May 27, 2022
- 28SEC EDGARForm 4 filed May 27, 2022
- 29SEC EDGARForm 4 filed May 12, 2022